neoplasia Flashcards

1
Q

what type of neoplasia has an increased mitotic index

A

malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

define neoplasia

A

abnormal (excessive) cell growth and differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

define neoplasm

A

an abnormal mass (tumor)

can be malignant or benign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

characteristics of malignant neoplasms

A
  • undifferentiated cells (anaplasia)
  • rapid, variable growth rate
  • growth by invasion, infiltration of surrounding tissue
  • metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

characteristics of benign neoplasms

A
  • well-differentiated
  • slower growth rate, may stop or regress
  • growth by expansion (doesn’t invade)
  • usually encapsulated
  • does not metastasize
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

genes code for what

A

proteins, which have a function and do tasks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

DNA repair genes

A
  • “spell check” genes
  • continuously read genetic code looking for errors (insertion/deletion/substitution) and deletes mistake
  • fixes the problem now instead of removing the cell later
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

why do carcinogens target DNA repair genes

A

allows mutations to pass through

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the cancer associated genes

A
  • proto-oncogenes (go)

- tumor suppressor genes (stop)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

proto-oncogenes

A
  • go genes = promote cell growth

- mutation = excessive cell growth = tumors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

tumor suppressor genes

A
  • stop genes = inhibit cell growth
  • mutation = excessive cell growth = tumors
  • ex. TP53
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are oncogenes

A

any mutated cancer associated gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

suffix for a benign tumor

A

oma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

suffix’s for malignant tumors

A

carcinoma

sarcoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

carcinoma refers to

A

arising from the epithelial tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

sarcoma refers to

A

arising from mesenchyme origins (non-epithelial)

mesenchyme = embryonic tissue (present only in embryo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

how long does it take for a tumor to double

A

120 days (4 months)

18
Q

how long does it take for a tumor to be clinically detectable

A

10 years

= 30 doublings, 1 cm in size, 1 billion cells

19
Q

the size of a tumor is directly related to what

A

the number of cells

20
Q

what does the TP53 gene code for

A

apoptosis of cells with DNA damage

21
Q

50% of cancers have what mutated gene and what does it cause

A

TP53

increased survival of DNA damaged cells

22
Q

methods of tumor spreading

A
  • local = invasion of surrounding tissue
  • seeding = distant spread within body cavities
  • metastasis = distant spread through blood/lymph
23
Q

what is a primary site?

A

where the tumor first formed

24
Q

what is a secondary site? most common secondary site?

A
where the CA cells spread to and proliferate 
lymphatic tissue (lymph nodes)
25
sentinel lymph node
first lymph node affected by cancerous cells
26
after the secondary site, where do malignant cells usually travel to
liver, lungs, bones, brain
27
stage 1 of metastasis
- cells invade local tissue aided by enzymes that break up cementing material between cells - malignant cells enter blood/lymph (emboli) - 1/1000 cells survive defenses (blood turbulance makes it easier by dislodging them), survival aided by platelets that cover/protect them
28
stage 2 of metastasis
- cells travel until they reach an area of resistance (capillary beds) - mediators (cytokines) scout and determine suitability of secondary site - cells attach and proliferate (aided by cytokines and growth factor)
29
what determines suitability of a secondary site
- resources for growth and division - protection from defenses - room to grow
30
stage 3 of metastasis
- cell proliferation and angiogenesis | - requires resources (nutrients, energy, waste removal)
31
grading of tumors
I to IV I = restrictive growth, IV = extensive growth subjective, based on histology higher grade = more anaplasia (worse outcome)
32
staging of tumors
TNM T: 0-4 (size/measurement) N: 0-3 (degree of lymph node involvement) M: 0-1 (metastasis - spread to secondary site) objective, clinical approach, global system
33
T1N0M0
small tumor, no lymph node involvement, no metastasis
34
T4N3M1
large tumor, many lymph nodes involved, metastases
35
treatment of cancer
- surgery - radiation - chemotherapy - immunotherapy - hormone therapy - combination therapy
36
when can a tumor be surgically removed
- it must be restricted in growth and well defined - not effective for advanced malignancy (multiple sites) - direct, least SE
37
why is radiation used for tumor treatment
- tumor cells proliferate uncontrollably, radiation prevents this by creating free radicals that destroy cells and disrupt/prevent DNA replication - problem: also kills and prevents division of normal cells
38
what does chemotherapy target
cell proliferation - rapidly growing cells | DNA, RNA, enzymes and protein synthesis
39
what does immunotherapy do
- stimulates the immune system to target malignant cells - CA cell destruction via cytokines, Ab, Ag - ex. provide Ag that resembles malignant cells
40
what does hormone therapy do
- disrupts hormonal supply that feeds the tumor | - disrupts cell fx
41
what is combination therapy used for
advanced disease or difficult to cure CA
42
problems with cancer treatment
- pressing side effects - hard to restrict malignant cells - normal rapidly proliferating cells also targetted - recurrence of growth, despite previous cure